共 190 条
[11]
Schotten U(2013)An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation Europace 15 652-662
[12]
Savelieva I(2009)Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies Mayo Clin Proc 84 643-1953
[13]
Ernst S(1994)Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154 1945-977
[14]
Van Gelder IC(2011)Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients Thromb Haemost 106 968-592s
[15]
Al-Attar N(2008)Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 546s-1419
[16]
Hindricks G(2007)Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action Arch Intern Med 167 1414-2389
[17]
Prendergast B(1997)Warfarin use among patients with atrial fibrillation Stroke 28 2382-131
[18]
Heidbuchel H(2014)Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial Eur J Cardiothorac Surg 45 126-988
[19]
Alfieri O(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 983-1740
[20]
Angelini A(2004)Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur Heart J 25 1734-638